Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience

Терапия аллогенными мезенхимальными стволовыми клетками: подход регенеративной медицины к геронауке
Joshua M. Hare, Anthony A. Oliva, Lisa McClain‐Moss, Andrea Pena, Amy Drouillard
2019-09-01

aging-associated disordersallogeneic mesenchymal stem cellsgerosciencehealthy agingregenerative medicine
Extraordinary advances in medicine and public health have contributed to increasing life expectancy worldwide. However, health span-"healthy aging"-has paradoxically lagged to parallel this increase. Consequently, aging-associated illnesses, such as Alzheimer's disease and aging frailty, are having a growing impact on patients, their families, and entire health-care systems. Typically, such disorders have been treated as isolated disease entities. However, the inextricable links between aging-associated disorders and the aging process itself have become increasingly recognized, leading to formation of the field of geroscience. The geroscience concept is that treating the aging process itself should lead to treatment and prevention of aging-related disorders. However, the aging process is complex, dictated by highly interrelated pleiotropic processes. As such, therapeutics with pleiotropic mechanisms of action (either alone, or as part of combinatorial strategies) will be required for preventing and treating both aging and related disorders. Mesenchymal stem cells (MSCs) have multiple mechanisms of action that make these highly promising geroscience therapeutic candidates. These cells have a high safety profile for clinical use, are amenable to allogeneic use since tissue-type matching is not required, and can have sustained activity after transplantation. Herein, we review preclinical and clinical data supporting the utility of allogeneic MSCs as a geroscience therapeutic candidate.
1
Allogeneic MSC therapy is clinically feasible because it generally does not require tissue-type matching, supporting its potential as a broadly applicable regenerative medicine approach.
2
Because aging involves interconnected and pleiotropic mechanisms, effective interventions may require therapies with broad, pleiotropic actions or combinatorial strategies.
3
Geroscience proposes targeting the aging process itself to prevent or treat multiple age-related disorders rather than addressing diseases in isolation.
4
Increasing life expectancy has not been matched by health span, contributing to a growing burden of aging-associated diseases and frailty.
5
Mesenchymal stem cells are promising geroscience candidates because they exert multiple mechanisms of action, have a favorable clinical safety profile, and can remain active after transplantation.

allogeneic mesenchymal stem cells as a geroscience therapeutic candidate

their utility for preventing and treating aging and aging-related disorders through pleiotropic mechanisms

Publication Details
Publication Date
2019-09-01
Journal
Publisher
ISSN
Cited by
26
Access Type
Author Information
Authors
Joshua M. Hare
Anthony A. Oliva
Lisa McClain‐Moss
Andrea Pena
Amy Drouillard
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%